Entremed (ENMD)

[tborges]

I tend to agree with you... I do believe that the group assembled by Tak and Mak are extremely capable and most importantly have a working knowledge of doing business in China... being fluent in the language as well as world class scientific credentials is a major asset...

The articles recently posted do make it clear that China is not going to be a quick and devious path to approval, but rather a progression through rigidly structured pre-clinical and clinical trials in which efficacy must be demonstrated.

The market potential in China cannot be overstated...but there is much work to be done...